Increasing age does not affect time to appropriate therapy in primary prevention ICD/CRT-D: a competing risks analysis.
Wilson, David G; Zeljko, Hrvojka Marija; Leventopoulos, Georgios; Nauman, Ahmed; Sylvester, George E H; Yue, Arthur; Roberts, Paul R; Thomas, Glyn; Duncan, Edward R; Roderick, Paul J; Morgan, John M.
; 19(2): 275-281, 2017 02 01.
Artigo em Inglês | MEDLINE | ID: mdl-28173045
Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter-defibrillators: The SHIELD-2 trial.
How implantable cardioverter-defibrillators work and simple programming.
The impact of serum potassium-influencing antihypertensive drugs on the risk of out-of-hospital cardiac arrest: A case-control study.
ESC-Leitlinien 2015 zu ventrikulären Arrhythmien und zur Prävention des plötzlichen Herztodes. Was ist neu?
Circumstances and outcomes of sudden unexpected death in patients with high-risk myocardial infarction: implications for prevention.
Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication.
Appropriate Implantable Defibrillator Therapy in Adults With Hypertrophic Cardiomyopathy.
Initial experience of subcutaneous implantable cardioverter defibrillators in Singapore: a case series and review of the literature.
Tpeak-Tend interval during therapeutic hypothermia can predict upcoming ventricular fibrillation in subjects with aborted arrhythmic sudden cardiac death: 3-years follow-up results.
Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone.